Vital Ksk Holdings (3151) · InitiativeRestated
Acquisition Synergies in the Veterinary Pharmaceutical Wholesale Business and the Pet Food Business
First written in FY2025. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Expanding the Business Portfolio and Operating Base Through M&A, Business Transfers and AlliancesA theme 56 companies write about · 0 as a headwind · 56 as a tailwind
9 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 56 companies compared. The sentences above are computed from all 56.Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「③ Veterinary pharmaceuticals wholesale business segment: To improve ROIC and generate stable free cash flow, the company will address the following practical priorities. 1) Maximize business synergies with Arrow Medical Co., Ltd., acquired last year. 2) Expand the new pet food business.」
The company continues to pursue maximizing synergies following the acquisition of Arrow Medical and expanding the pet food business as practical priorities. - FY2025First statedAnnual report
「③ Veterinary pharmaceuticals wholesale business segment: To improve ROIC and generate stable free cash flow, the company will address the following practical priorities. 1) Maximize business synergies with the peer acquired last year. 2) Expand the new pet food business.」
The company identifies maximizing business synergies following the acquisition of Arrow Medical and expanding the pet food business as new practical priorities.